FIT India References

1. Mohan V, Sandeep S, Deepa R, Shah B, Varghese C. Epidemiology of type 2 diabetes: Indian scenario. Indian J Med Res. 2007;125(3):217-30.
2. Anjana RM, Pradeepa R, Deepa M, Datta M, Sudha V, Unnikrishnan R et al. Prevalence of diabetes and prediabetes (impaired fasting glucose and/or impaired glucose tolerance) in urban and rural India: phase I results of the Indian Council of Medical Research-INdiaDIABetes (ICMR-INDIAB) study. Diabetologia. 2011;54(12):3022-7.
3. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Research and Clinical Practice. 2010;87:4-14.
4. Crasto W, Jarvis J, Khunti K, Davies MJ. New insulins and new insulin regimens: a review of their role in improving glycaemic control in patients with diabetes. Postgrad Med J. 2009 May;85(1003):257-67.
5. Prasad R. Innovate for Diabetes in India. Available from: http://blogs.novonordisk.com/graduates/2010/10/27/innovate-for-diabetes-in-india/ Accessed on June 01, 2012.
6. Yadav S, Parakh A. Insulin Therapy. Indian Pediatrics. 2006;43:863-872.
7. Gibney MA, Arce CH, Byron KJ, Hirsch LJ. Skin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections: implications for needle length recommendations. Curr Med Res Opin. 2010;26(6):1519-1530.
8. Hirsch LJ, Gibney MA, Li L, et al. Comparative glycemic control, safety and patientratings for a new 4mm\32G insulin pen needlein adults with diabetes. Curr Med Res Opin. 2010;26(6): 1531–1541.
9. Strauss K, De Gols H, Hannet I, Partanen TM, Frid A. A pan-European epidemiologic study of insulin injection technique in patients with diabetes. PractDiab Int. 2002; 19(3):71–6.
10. New UK recommendations for best practice in diabetes injection technique. Available from: http://www.primarycaretoday.co.uk/training/?pid=4216&lsid=4268&edname=29301.htm&ped=29301 Accessed on May 05, 2012.
11. Dolinar R. The Importance of Good Insulin Injection Practices in Diabetes Management. US Endocrinology. 2009;5(1):49-52.
12. Meechan JG. How to overcome failed local anesthesia. Br Dent J. 1999;186(1):15-20.
13. Gin H, Hanaire-Broutin H. Reproducibility and variability in the action of injected insulin. Diabetes Metab. 2005;31(1):7-13.
14. Kumar A, Kalra S. Insulin initiation and intensification: insights from new studies. J Assoc Physicians India. 2011;59 Suppl:17-22.
15. Davidson JA. New injection recommendations for patients with diabetes. Diabetes Metab. 2010;36Suppl 2:S2.
16. Frid A, Hirsch L, Gaspar R, Hicks D, Kreugel G, Liersch J et al. New injection recommendations for patients with diabetes. Diabetes Metab (French). 2010;36Suppl 2:S3-18.
17. Siminerio L, Kulkarni K, Meece J, Williams A, Cypress M, Haas L et al. Strategies of insulin injection therapy in diabetes self-management. Diabetes Educ. 2011; 37(6) Suppl 3:1-10.
18. Keininger D, Coteur G. Assessment of self-injection experience in patients with rheumatoid arthritis: psychometric validation of the Self-Injection Assessment Questionnaire (SIAQ). Health Qual Life Outcomes. 2011;9:2.
19. Kansra UC, Sircar S. Insulin therapy: Practical points. Journal, Indian Academy of Clinical Medicine.2000;1(3):285-93.
20. Okazaki K, Goto M, Yamamoto T, Tsujii S, Ishii H. Barriers and facilitators in relation to starting insulin therapy in type 2 diabetes (Abstract). Diabetes. 1999;48(Suppl. 1):A319.
21. American Diabetes Association: Insulin administration. Diabetes Care. 2004;27 (Suppl 1):S106-9.
22. Travel and Diabetes. Available from: http://www.sweet.org.au/docs/professionals/14_Travel_and_Diabetes.pdf Accessed on June 28, 2012.
23. Insulin syringes. Available from: http://www.bd.com/us/diabetes/page.aspx?cat=7001&id=7251 Accessed on May 21, 2012.
24. Gitanjali B. A tale of too many strengths: Can we minimize prescribing errors and dispensing errors with so many formulations in the market? J PharmacolPharmacother. 2011;2(3):147-9.
25. Syringe and pen needle sizes. Available from: http://www.bd.com/us/diabetes/page.aspx?cat=7001&id=7253 Accessed on May 22, 2012.
26. Holleman F, Vermeijden JW, Kuck EM, Hoekstra JB, Erkelens DW. Compatibility of insulin pens and cartridges. Lancet. 1997;350(9091):1601-2.
27. Insulin pens. Available from: http://www.bd.com/us/diabetes/page.aspx?cat=7001&id=7254 Accessed on May 22, 2012.
28. Skin thickness and needle size. Available from: http://www.bd.com/us/diabetes/page.aspx?cat=7001&id=32371 Accessed on May 22, 2012.
29. Lo Presti D, Ingegnosi C, StraussK.Skin and subcutaneous thickness at injecting sites in children with diabetes: ultrasound findings and recommendations for giving injection. Pediatr Diabetes.2012[Epub ahead of print]
30. Yadav S. Insulin therapy. Indian Pediatrics. 2006;43:863-72.
31. Injection site selection. Available from: http://www.bd.com/us/diabetes/page.aspx?cat=7001&id=7261 Accessed on May 21, 2012.
32. Down S, Kirkland F. Injection technique in insulin therapy. Nurs Times 2012;108(10):18, 20-1.
33. Basi M, Hicks D, Kirkland F, Pledger J, Burmiston S. Improving diabetes injection technique. The Clinical Services Journal. 2010.
34. How to inject an insulin syringe. Available from: http://www.bd.com/us/diabetes/page.aspx?cat=7001&id=7258 Accessed on May 22, 2012.
35. Bohannon NJV. Insulin delivery using pen devices: simple-to-use tools may help young and old alike. Postgrad Med. 1999:106(5):57-68.
36. Czupryniak L, Drzewoski J. Insulin injection mean time interval it is NOT its length that matters. PractDiab Int. 2001;18(9):338.
37. Fowler MJ. Diabetes Treatment, Part 3: Insulin and Incretins. Clinical Diabetes. 2008;26(1):35-9.
38. Kumar Das A. Rapid Acting Analogues in Diabetes Mellitus Management. Journal of the Association of Physicians of India. 2009. Available from: http://www.japi.org/february_2009/rapid_acting_analogue.html Accessed on June 28, 2012.
39. Deckert T. Intermediate-acting Insulin Preparations: NPH and Lente. Diabetes care. 1980;3(5):623-6.
40. Lantus Product Monograph. Available from: http://products.sanofi.ca/en/lantus.pdf Accessed on June 28, 2012.
41. Workman B. Safe injection techniques. Nursing standard. 1999;13 (39):47-53.
42. Misnikova IV, Dreval AV, Gubkina VA, Rusanova EV. The risks of repeated use of insulin pen needles in patients with diabetes mellitus. Journal of Diabetology. 2011;1(1):1-5.
43. Guidelines on safe disposal of Used Needles and Syringes in the Context of Targeted Intervention for Injecting Drug Users Available from: http://nacoonline.org/upload/NGO%20&%20Targeted/waste%20disposal%20guideline%20for%20IDU%20TI.pdf Accessed on 20 Aug, 2012.
44. WISE consensus group. WISE recommendations to ensure the safety of injections in diabetes. Available from: http://www.emanet.org/docs/New%20Recommendations%20WISE.pdf Accessed on May 18, 2012.
45. Palios J, Kadoglou NP, Lampropoulos S. The pathophysiology of HIV-/HAART-related metabolic syndrome leading to cardiovascular disorders: the emerging role of adipokines. Exp Diabetes Res. 2012;2012:103063.
46. Kalra S, Unnikrishnan AG, Raza SA, et al. South Asian Consensus Guidelines for the rational management of diabetes in human immunodeficiency virus/acquired immunodeficiency syndrome. Indian J EndocrMetab. 2011;15:242-50.
47. Strauss K; WISE Consensus Group. WISE recommendations to ensure the safety of injections in diabetes. Diabetes Metab. 2012;38Suppl 1:S2-8.
48. Beran D. Improving access to insulin: what can be done? Diabetes management. 2011;1(1):67-76.
49. Kalra S, Kalra B. A good diabetes counselor ‘Cares’: Soft skills in diabetes counseling. The Internet Journal of Health. 2010;11(1):1-3.
50. Kalra S, Kalra B, Batra P. Patient Motivation for Insulin/Injectable Therapy: The Karnal Model. International Journal of Clinical Cases and Investigations. 2010;1(5):11-5.